HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients.

Abstract
Glucagon-like peptide 1 (GLP-1) has antidiabetic effects and many facets of Type 2 diabetes could theoretically be the consequence of a reduction in or lack of GLP-1 function. Exogenous GLP-1 is exquisitely effective in Type 2 diabetic patients, making receptor defects unlikely. GLP-1 responses after meals as detected by radioimmunoassay are not overtly reduced in Type 2 diabetic patients. Therefore, a sequence analysis of exon 2 of the preproglucagon gene coding for the GLP-1 protein was initiated in order to exclude potential germline mutations. 24 Type 2 diabetic patients and in 14 control subjects with normal oral glucose tolerance (WHO criteria) were studied. In all specimens of peripheral blood leukocyte DNA examined, no germline mutations of the GLP-1 sequence were identified, thus excluding mutations in the GLP-1 sequence as a major contributor to the pathophysiological appearance of the Type 2 diabetic phenotype. Rare mutations, however, cannot be excluded due to the small number of Type 2 diabetic patients examined.
AuthorsM Nauck, S Hahn, A Sauerwald, W Schmiegel
JournalExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (Exp Clin Endocrinol Diabetes) Vol. 108 Issue 2 Pg. 72-5 ( 2000) ISSN: 0947-7349 [Print] Germany
PMID10826511 (Publication Type: Journal Article)
Chemical References
  • Insulin
  • Peptide Fragments
  • Protein Precursors
  • Proglucagon
  • Glucagon-Like Peptide 1
  • Glucagon
Topics
  • Aged
  • Amino Acid Sequence
  • Base Sequence
  • Diabetes Mellitus, Type 2 (genetics, physiopathology)
  • Female
  • Glucagon (chemistry, genetics, pharmacology)
  • Glucagon-Like Peptide 1
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation
  • Peptide Fragments (chemistry, genetics, pharmacology)
  • Proglucagon
  • Protein Precursors (chemistry, genetics, pharmacology)
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: